BioSpace News Archive

Pharm Country

Neuronetics® Unveils Promising New Depression Research Data at Psych Congress

New findings confirm safety and efficacy of NeuroStar® Advanced Therapy, a non-drug depression treatment, setting the stage for future indications

October 3, 2019
·
9 min read
Drug Development

New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions in Total Symptom Score, Mucus Weight and RSV Viral Load

Enanta plans to initiate a Phase 2b clinical study of EDP-938 in adult out-patients with RSV by the end of 2019.

October 3, 2019
·
6 min read
BioMidwest

BacterioScan To Announce Disruptive Approach For Rapid Identification Of Pathogens That Cause Infectious Disease In Humans At IDWeek

BacterioScan’s versatile infectious disease diagnostic platform will combine pathogen detection, identification, and antimicrobial susceptibility testing into a fast, accurate and affordable test

October 3, 2019
·
2 min read
Job Trends

Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor’s Choice

Article Reviewing Rapid Acoustic Pulse Technology to be included in next “Lasers in Surgery and Medicine” Journal

October 3, 2019
·
3 min read
Genetown

Blue Cross Blue Shield Of Massachusetts Adds Acupuncture Coverage

State’s largest health plan adds benefit to increase options for non-opioid pain relief

October 3, 2019
·
3 min read
Perrigo Announces the Relaunch of the AB Rated Generic Version of Transderm Scop® 1.5 MG

Perrigo Company plc announced the relaunch of the AB rated generic equivalent of Transderm Scop®.

October 3, 2019
·
4 min read
Drug Development

Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NAFLD and NASH

Statistically significant 44.39 % reduction in ALT (alanine aminotransferase) observed with Saroglitazar Magnesium treated patients

October 3, 2019
·
3 min read
Job Trends

Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes

From IDWeek™, the annual meeting of the Infectious Diseases Society of America (IDSA) held in Washington, DC October 2 - 6.

October 3, 2019
·
7 min read
Deals

Tocagen Announces Restructuring to Focus on Clinical Development

Toca 5 full results to be presented at the upcoming Society for Neuro-Oncology Annual Meeting

October 3, 2019
·
3 min read
Business

Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero’s 3D InSight™ Human Liver Disease platform

3D InSight™ Human Liver Disease Platform will be used to screen effects of Akero lead program AKR-001 on underlying metabolic and fibrotic drivers of NAFLD and NASH.

October 3, 2019
·
5 min read